Switzer TV

Switzer Investing TV | 12 May 2025

Jun Bei Liu talks us through some rare stock picks and talks the potential US-China trade deal, we walk through the charts and talk WBC, MQG and BHP, and ask a bullion expert: why is Gen Z suddenly buying gold?

More videos

COVID-19: Great for retail stocks! Plus, these charts will make you want to buy stocks!

On this week's show: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, ELMO's Danny Lessem, Morgans' Raymond Chan and Switzer's Paul Rickard.

Series: ,
How does herd immunity work?

Dr Ross explains herd immunity and how it could work in the case of COVID-19.

Series: ,
Mad about Money Live!

Catch up with Peter Switzer and Paul Rickard for the latest money news locally and overseas.

Series: ,
Afterpay a sell? Top stocks big gains ahead?

Fortescue CEO Elizabeth Gaines joins this week's show, along with Burman Invest's Julia Lee, Shawn and Partners' Adam Dawes and Switzer's Paul Rickard.

Series: ,
Did health authorities make the right decision about COVID-19?

Dr Ross Walker shares his criticisms about how the coronavirus pandemic has been handled.

Series: ,
Time for Gladys to mask up!

Peter Switzer and Paul Rickard discuss masking up for the economy, rising gold prices and the looming reporting season.

Series: ,
Experts give these tech stocks a thumbs up!

On this week's show: Burman Invest's Julia Lee, Medallion's Michael Wayne, Morgans' Michael Knox and Switzer's Paul Rickard.

Series: ,
What therapies are available for COVID-19?

Dr Ross Walker examines the effectiveness of hydroxychloroquine.

Series: ,
Why is the stock market ignoring infections?

Peter Switzer and Paul Rickard discuss gains in the stock market despite infection rates in Victoria and the US, the Aussie dollar moving above 71 US cents and when employees will head back to the office.

Series: ,
Could Afterpay really go to $100? Plus, reliable stocks you can trust!

Joining Peter Switzer on this week's show: Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes, FNArena's Rudi Filapek-Vandyck and Metrics Credit Partners' Andrew Lockhart.

Series: ,
The COVID-19 game-changer

With over 100 vaccines for COVID-19 currently being trialled, Dr Ross Walker explains what vaccination is and how the latest research into Coronavirus vaccines is progressing.

Series: ,
Steven Turner from Rafaella Resources (ASX:RFR)

Peter Switzer is joined by the Managing Director of Rafaella Resources (RFR), Steven Turner.

Series: ,
1 41 42 43 44 45 50

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram